| [1] |
Chu H, Zhong L, Li H, et al. Epidemiology characteristics of constipation for general population, pediatric population, and elderly population in China[J]. Gastroenterology Research and Practice, 2014, 2014:1-11.
|
| [2] |
Roque MV, Bouras EP. Epidemiology and management of chronic constipation in elderly patients[J]. Clin Interv Aging, 2015, 10:919-930.
|
| [3] |
中华医学会老年医学分会，中华老年医学杂志编辑委员会.老年人慢性便秘的评估与处理专家共识[J].中华老年医学杂志，2017，36（4）：371-381.
|
| [4] |
方秀才.难治性便秘的处理[J].中华消化杂志，2016，36（5）：291-294.
|
| [5] |
中华医学会消化病学分会胃肠动力学组，中华医学会外科学分会结直肠肛门外科学组.中国慢性便秘诊治指南（2013年，武汉）[J].中华消化杂志，2013，33（5）：291-297.
|
| [6] |
Emmanuel A, Quigley EM, Simren M, et al. Factors affecting satisfaction with treatment in European women with chronic constipation: An internet survey[J]. United European Gastroenterol J, 2013, 1(5):375-384.
|
| [7] |
郁强，刘薇，蒋静，等.不同泻药致豚鼠结肠黑变病的实验研究[J].北京中医药大学学报，2018，41（1）：53-59.
|
| [8] |
Yu QJ, Yu SY, Zuo LJ, et al. Parkinson disease with constipation: clinical features and relevant factors[J]. Sci Rep, 2018, 8(1):567.
|
| [9] |
Winge K, Rasmussen D, Werdelin LM. Constipation in neurological diseases[J]. J Neurol Neurosurg Psychiatry, 2003, 74(1):13-19.
|
| [10] |
Gau JT, Acharya UH, Khan MS, et al. Risk factors associated with lower defecation frequency in hospitalized older adults: a case control study[J]. BMC Geriatrics, 2015, 15(1):44.
|
| [11] |
Fosnes GS, Lydersen S, Farup PG. Constipation and diarrhoea-common adverse drug reactions? A cross sectional study in the general population[J]. BMC Clin Pharmacol, 2011, 11(1):2.
|
| [12] |
Huang L, Jiang H, Zhu M, et al. Prevalence and risk factors of chronic constipation among women aged 50 years and older in Shanghai, China[J]. Med Sci Monit, 2017, 23:2660-2667.
|
| [13] |
Iovino P, Chiarioni G, Bilancio G, et al. New onset of constipation during long-term physical inactivity: a proof-of-concept study on the immobility-induced bowel changes[J]. PLoS One, 2013, 8(8):e72608.
|
| [14] |
李小雯，郑松柏.老年人虚弱症[J].国际老年医学杂志，2014，35（2）：75-79.
|
| [15] |
孟丽，于普林.英国老年医学会老年人衰弱管理实践指南解读[J].中华老年医学杂志，2015，34（12）：1300-1302.
|
| [16] |
Tillou J, Poylin V. Functional disorders: slow-transit constipation[J]. Clin Colon Rectal Surg, 2017, 30(1):76-86.
|
| [17] |
张东铭.盆底松弛型便秘治疗学新概念[J].中国肛肠病杂志，2011，31（9）：68-69.
|
| [18] |
Iglesia CB, Smithling KR. Pelvic organ prolapse[J]. Am Fam Physician, 2017, 96(3):179-185.
|
| [19] |
Patcharatrakul T, Rao S. Update on the pathophysiology and management of anorectal disorders[J]. Gut Liver, 2018, 12(4):375-384.
|
| [20] |
Mahajan R. Prucalopride: a recently approved drug by the food and drug administration for chronic idiopathic constipation[J]. Int J Appl Basic Med Res, 2019, 9(1):1-2.
|
| [21] |
Camilleri M, Piessevaux H, Yiannakou Y, et al. Efficacy and safety of prucalopride in chronic constipation: An integrated analysis of six randomized, controlled clinical trials[J]. Dig Dis Sci, 2016, 61(8):2357-2372.
|
| [22] |
Omer A, Quigley E. An update on prucalopride in the treatment of chronic constipation[J]. Therap Adv Gastroenterol, 2017, 10(11):877-887.
|
| [23] |
Yiannakou Y, Piessevaux H, Bouchoucha M, et al. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation[J]. Am J Gastroenterol, 2015, 110(5):741-748.
|
| [24] |
Hayat M, Zia H, Nusrat S. Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes[J]. Patient Relat Outcome Meas, 2019, 10:43-47.
|
| [25] |
Li F, Fu T, Tong WD, et al. Lubiprostone is effective in the treatment of chronic idiopathic constipation and irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials[J]. Mayo Clin Proc, 2016, 91(4):456-468.
|
| [26] |
Love BL, Johnson A, Smith LS. Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome[J]. Am J Health Syst Pharm, 2014, 71(13):1081-1091.
|
| [27] |
Nee JW, Johnston JM, Shea EP, et al. Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis[J]. Expert Rev Gastroenterol Hepatol, 2019, 13(4):397-406.
|
| [28] |
Fukudo S, Miwa H, Nakajima A, et al. High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan[J]. Neurogastroenterol Motil, 2019, 31(1):e13487.
|
| [29] |
Kamm MA, Mueller-Lissner S, Wald A, et al. Oral bisacodyl is effective and well-tolerated in patients with chronic constipation[J]. Clin Gastroenterol Hepatol, 2011, 9(7):577-583.
|
| [30] |
Noergaard M, Traerup AJ, Jimenez-Solem E, et al. Long term treatment with stimulant laxatives-clinical evidence for effectiveness and safety[J]. Scand J Gastroenterol, 2019, 54(1):27-34.
|
| [31] |
Izzy M, Malieckal A, Little E, et al. Review of efficacy and safety of laxatives use in geriatrics[J]. World J Gastrointest Pharmacol Ther, 2016, 7(2):334-342.
|
| [32] |
Morales MA, Hernandez D, Bustamante S, et al. Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity[J]. J Toxicol, 2009, 2009:1-8.
|
| [33] |
Alsalimy N, Madi L, Awaisu A. Efficacy and safety of laxatives for chronic constipation in long-term care settings: A systematic review[J]. J Clin Pharm Ther, 2018, 43(5):595-605.
|
| [34] |
王晓辉，崔立红，闫志辉，等.多库酯钠治疗慢性功能性便秘的疗效分析[J].解放军药学学报，2013，29（6）：578-580.
|
| [35] |
Etherson KJ, Minty I, Bain IM, et al. Transanal irrigation for refractory chronic idiopathic constipation: Patients perceive a safe and effective therapy[J]. Gastroenterol Res Pract, 2017, 2017:1-6.
|
| [36] |
Emmanuel AV, Krogh K, Bazzocchi G, et al. Consensus review of best practice of transanal irrigation in adults[J]. Spinal Cord, 2013, 51(10):732-738.
|
| [37] |
Rao SS, Benninga MA, Bharucha AE, et al. ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders[J]. Neurogastroenterol Motil, 2015, 27(5):594-609.
|
| [38] |
Narayanan SP, Bharucha AE. A practical guide to biofeedback therapy for pelvic floor disorders[J]. Curr Gastroenterol Rep, 2019, 21(5):21.
|
| [39] |
李刚，王永兵，郑君华，等.生物反馈训练疗法在老年功能性便秘患者中的应用效果[J].中华老年医学杂志，2017，36（12）：1318-1322.
|
| [40] |
中国医师协会肛肠医师分会.便秘外科诊治指南(2017)[J].中华胃肠外科杂志，2017，20（3）：241-243.
|
| [41] |
Chung SH, Kim WB. Various approaches and treatments for pelvic organ prolapse in women[J]. J Menopausal Med, 2018, 24(3):155-162.
|